- $9.80bn
- $8.65bn
- $2.74bn
- 95
- 51
- 65
- 81
Annual income statement for Nice, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,648 | 1,921 | 2,181 | 2,378 | 2,735 |
| Cost of Revenue | |||||
| Gross Profit | 1,086 | 1,297 | 1,498 | 1,609 | 1,826 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,406 | 1,657 | 1,846 | 1,942 | 2,189 |
| Operating Profit | 242 | 264 | 335 | 435 | 546 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 237 | 241 | 345 | 458 | 605 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 196 | 199 | 266 | 338 | 443 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 197 | 200 | 265 | 337 | 439 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 197 | 200 | 265 | 337 | 439 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3 | 3.01 | 3.99 | 5.23 | 6.74 |
| Dividends per Share |